Abstract
Introduction

38
Wolbachia is an obligate intracellular, intraovarially-transmitted bacterium living in symbiosis 
51
Wolbachia can also provide infected individuals with fitness benefits: nutrient provisioning (6), 52 increase in reproductive output (7), and protection against pathogens (8, 9). The latter is also being 53 used to eliminate vector-borne diseases. Aedes aegypti mosquitos artificially transinfected with 54 protective Wolbachia are being deployed as a strategy to eradicate dengue virus (10) (11) (12) (13) (14) (15) . The data 55 from one of the first release sites in Australia suggest that this strategy may limit the number of 56 dengue cases in humans (15).
57
Malaria is a mosquito-borne disease that threatens around half of the world's population (16). The 58 potential for the use of Wolbachia to block malaria has been recognized since the symbiont's anti-59 viral and anti-parasitic properties were first demonstrated in other insects (8-10, 17). However,
60
Anopheles mosquitos were for long considered inhospitable for Wolbachia (18) (19) (20) Anopheles gambiae biology is crucial for the design of effective strategies aiming at limiting
246
Plasmodium transmission.
247
Targeted Wolbachia-based Plasmodium control strategies, similar to the ones used for dengue and The presence and, subsequently, Plasmodium blocking properties of the presumed natural concatenated core genome alignments of all strains with a (draft) genome in NCBI. Again, the 485 strain isolated from SAMEA3911293 is highlighted in blue.
